Erling T. Donnelly
Pfizer (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Photodynamic Therapy Research Studies, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Radiation Therapy and Dosimetry
Most-Cited Works
- → Preliminary studies of the effects of gadolinium texaphyrin on the growth and radiosensitivity of EMT6 cells in vitro(2002)26 cited
- → Effects of texaphyrins on the oxygenation of EMT6 mouse mammary tumors(2004)26 cited
- → Preparation of substituted transition-metal (η1-propargyl complexes and their [3+2] cycloaddition reactions with sulfur dioxide and disulfur monoxide. Transition-metal–carbon bond cleaving reactions of the cycloadducts which yield oxathiolene oxides and dithiolene oxides(2003)17 cited
- → Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity(2016)16 cited
- → Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib(2016)15 cited
- → Effects of motexafin gadolinium on DNA damage and X-ray-induced DNA damage repair, as assessed by the Comet assay(2005)13 cited
- → Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo(2003)8 cited
- → Efaproxiral (RSR13) Plus Oxygen Breathing Increases the Therapeutic Ratio of Carboplatin in EMT6 Mouse Mammary Tumors(2006)6 cited
- → The effect of palbociclib (P) in combination with letrozole (L) on bone metastases in women with ER+/ HER2- metastatic breast cancer (MBC): Subanalysis from a randomized phase II study.(2015)3 cited
- → Effects of texaphyrins on the oxygenation of EMT6 mouse mammary tumors1, *1(2004)1 cited